First clinical application of cord blood mesenchymal stromal cells in children with multi-drug resistant nephrotic syndrome

Abstract Background and objectives Children with multi-drug resistant idiopathic nephrotic syndrome (MDR-INS) usually progress to end-stage kidney disease with a consistent risk of disease recurrence after transplantation. New therapeutic options are needed for these patients. Mesenchymal stromal ce...

Descrición completa

Detalles Bibliográficos

Principais autores:	William Morello, Silvia Budelli, Daniel Ari Bernstein, Tiziana Montemurro, Elisa Montelatici, Cristiana Lavazza, Luciana Ghio, Alberto Edefonti, Licia Peruzzi, Daniela Molino, Elisa Benetti, Bruno Gianoglio, Florian Mehmeti, Laura Catenacci, Jessica Rotella, Chiara Tamburello, Antonia Moretta, Lorenza Lazzari, Rosaria Giordano, Daniele Prati, Giovanni Montini
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2022-08-01
Series:	Stem Cell Research & Therapy
Assuntos:	Idiopathic nephrotic syndrome Mesenchymal stromal cells Multi-drug resistant nephrotic syndrome Children Advanced therapy medical products Cord-blood-derived mesenchymal stromal cells
Acceso en liña:	https://doi.org/10.1186/s13287-022-03112-7
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!